Synthomer (LON:SYNT – Get Free Report) had its price target lifted by Deutsche Bank Aktiengesellschaft from GBX 92 to GBX 100 in a report released on Wednesday,Digital Look reports. The firm currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price would suggest a potential downside of 8.26% from the stock’s previous close.
Several other equities research analysts have also recently commented on SYNT. Jefferies Financial Group reissued a “hold” rating and set a GBX 65 target price on shares of Synthomer in a report on Thursday, April 30th. Peel Hunt restated a “buy” rating and set a GBX 200 price objective on shares of Synthomer in a research report on Tuesday. Finally, Berenberg Bank boosted their target price on shares of Synthomer from GBX 60 to GBX 100 and gave the stock a “hold” rating in a report on Wednesday, May 6th. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of GBX 117.
Read Our Latest Stock Report on Synthomer
Synthomer Stock Performance
Synthomer (LON:SYNT – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported GBX (4.30) EPS for the quarter. Synthomer had a negative net margin of 9.03% and a negative return on equity of 16.66%. On average, equities research analysts forecast that Synthomer will post 12.962963 earnings per share for the current year.
Synthomer Company Profile
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,800 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
Read More
- Five stocks we like better than Synthomer
- AMD’s Post-Earnings Drop May Be the Opportunity Investors Wanted
- 3 Stocks That Prove the AI Trade Isn’t Over, It Moved
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.
